(+)-Methamphetamine hydrochloride
SIGMA/M8750
Synonym: d-Desoxyephedrine hydrochloride; d-N,α-Dimethylphenethylamine hydrochloride; Methylamphetamine hydrochloride
CAS Number: 51-57-0
Empirical Formula (Hill Notation): C10H15N · HCl
Molecular Weight: 185.69
EC Number: 200-106-9
MDL Number: MFCD00056130
Linear Formula: C10H15N · HCl
Product Type: Chemical
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material. This image depicts SKU: M8750-25G
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material. This image depicts SKU: M8750-100MG
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material. This image depicts SKU: M8750-5G
| application(s) | forensics and toxicology pharmaceutical (small molecule) veterinary |
| drug control | USDEA Schedule II; Home Office Schedule 2; stupéfiant (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal) |
| InChI | 1S/C10H15N.ClH/c1-9(11-2) |
| InChI key | TWXDDNPPQUTEOV-FVGYRXGTSA |
| originator | Teva |
| Quality Level | 200  |
| SMILES string | Cl[H].CN[C@@H](C)Cc1ccccc |
| solubility | ethanol: soluble |
| H2O: soluble | |
| technique(s) | gas chromatography (GC): suitable |
| HPLC: suitable |
| Biochem/physiol Actions: | Sympathomimetic with more potent central effects than amphetamine. It is transported into terminals via the monoamine transporters and induces release of dopamine, norepinephrine, epinephrine, and serotonin. Dopamine release is important for the addictive properties of methamphetamine while norepinephrine and epinephrine release are important for the cardiovascular effects. Serotonin neurotoxin. |
| Features and Benefits: | This compound was developed by Teva . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Symbol |  GHS06 |
| Signal word | Danger |
| Hazard statements | H300 - H336 |
| Precautionary statements | P301 + P310 + P330 |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | UN 2811 6.1 / PGII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 12352200 |